Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Active vitamin D supplementation and COVID-19 infections: review
Nakhoul Farid
, Nakhoul Rola
, Elias A.T. Koch
, Nakhoul Nakhoul
Bar-Ilan University - Azrieli Faculty of Medicine
Baruch Padeh Poriya medical Center
Friedrich-Alexander University Erlangen-Nürnberg
Poriya Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Active vitamin D supplementation and COVID-19 infections: review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
COVID-19
100%
Vitamin D
100%
Vitamin D Supplementation
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Active Vitamin D
100%
Anti-inflammatory Effect
50%
Vitamin D Status
50%
Angiotensin-converting Enzyme 2 (ACE2)
50%
Randomized Controlled Trial
25%
Antiviral Activity
25%
Elderly Patients
25%
Antimicrobial Activity
25%
Global Pandemic
25%
Conflicting Results
25%
Protective Effect
25%
Lethal Infection
25%
Diabetes Mellitus
25%
Cytokine Storm
25%
Chronic Kidney Disease
25%
Pneumonia
25%
Arterial Hypertension
25%
High Mortality
25%
Severe Cases
25%
Immunosuppressive Therapy
25%
Immunomodulator
25%
Alveolar Epithelial Cells
25%
Renal Tubular Epithelial Cells
25%
Immunomodulatory Effect
25%
High Morbidity
25%
Direct Inhibitors
25%
Viral Replication
25%
Host Receptor
25%
Viral Respiratory Infections
25%
Spike Glycoprotein
25%
Severe Acute Respiratory Syndrome
25%
Immune Evasion
25%
Patients with Chronic Diseases
25%
Chloroquine
25%
Viral Inhibition
25%
Convalescent Plasma
25%
Acute Respiratory Distress Syndrome
25%
Public Health Emergency
25%
Good Outcome
25%
Transplanted Patients
25%
Plasma Infusion
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Vitamin D
100%
SARS Coronavirus
44%
Angiotensin Converting Enzyme 2
22%
Randomized Controlled Trial
11%
Retrospective Study
11%
Pandemic
11%
Immunomodulating Agent
11%
Morbidity
11%
Antivirus Agent
11%
Chronic Disease
11%
Receptor
11%
Syndrome
11%
Chronic Kidney Failure
11%
Immunosuppressive Agent
11%
Viral Respiratory Tract Infection
11%
Glycoprotein
11%
Chloroquine
11%
Acute Respiratory Tract Disease
11%
Cytokine Storm
11%
Diabetes Mellitus
11%
Diseases
11%
Antimicrobial Agent
11%
Pneumonia
11%
Spike Protein
11%